Maryland, 8 March 2024: The U.S. Food and Drug Administration approved Amtagvi (lifileucel), the first cellular therapy indicated for the treatment of adult patients with a type of skin cancer (melanoma) that is unable to be removed with surgery (unresectable) or has spread to ot......
View Details

Related News

• Centre plans to establish national regulatory framework for AYUSH: Union Minister Jadhav (18-01-2025)

---

• Smuggler arrested with 1000 Phensedyl cough syrup bottles, handed over to police (18-01-2025)

---

• STF of Bengal Police seized consignment of banned Phensedyl cough syrup worth Rs 1.5 crore (18-01-2025)

---

• DGFT issues new SOP for voluntary disclosure of SCOMET violations (18-01-2025)

---

• Private bodies providing essential services must fall under RTI Act: CIC (18-01-2025)

---

• 'In-Depth' Probe in Anaesthesia Drugs Complication Cases in Kashmir (18-01-2025)

---

• Guidelines to tackle Antimicrobial Resistance with Better Testing Machines (18-01-2025)

---

• IBM and L’Oreal to use gen AI model for sustainable cosmetic formulation (17-01-2025)

---

• Medical devices sector shows promising growth (17-01-2025)

---

• Nichlaul: Police arrested for running shop without license for 12 years (17-01-2025)

---